Aww dr_nisjobe, and all your other hatespewing IDs. You must know that your hateful mindset will just snuff out whatever you have left of the pilot light of your soul. You should concentrate on preserving whatever soul you have left. And get back on your meds, our acting like a fool!
U R So FOS Your Post Stinks 4 Miles. Take a Walk Around, "mate". Nobody on this message board is going to pay any attention to a POS like yourself! Go back and jerk off on the ANX board where you belong......LMFAO @ this moron
He's got a B.S. degree in Political Science and experience in Real Estate for God's sake. Just a paid Blogster tool, only paid attention to be a FOOL!
Liars are trying to get you to lose money here. read the articles for yourself
Affymax (AFFY) submitted its 4th quarter 2012 results and annual report yesterday, and it was not a pretty sight. AFFY wasn't financially prepared to deal with the recent recall of its dialysis drug, OMONTYS.
Its Q412 loss was $68.3 million (or $1.85 per share), a large chunk was from $45.0 million in impairment due to inventory and firm purchase commitments from its recall of OMONTYS. Interestingly, the company didn't set aside any funds in anticipation of the inevitable lawsuits from patients who had a severely bad reaction to OMONTYS.